Abstract:Guocan Yu, 1 Yanqin Shen, 2 Liwei Yao, 2 Xudong Xu 1 1 Zhejiang Tuberculosis Diagnosis and Treatment Center, Hangzhou Red Cross Hospital, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Nursing, Hangzhou Red Cross Hospital, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China Correspondence: Liwei Yao; Xudong Xu, Email ; Purpose: This study aimed to evaluate the efficacy of nanopore sequencing for diagnosing pulmonary tuberculosis (PTB) using smear-negative clinical specimens. Methods: We conducted a retrospective study based on a review of patient medical records to assess the accuracy of nanopore sequencing as a diagnostic tool for smear-negative PTB. Compared with clinical diagnosis, we determined the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) of nanopore sequencing. Results: A total of 647 patients were evaluated. Nanopore sequencing demonstrated an overall sensitivity of 91.7%, specificity of 85.3%, PPV of 95.1%, NPV of 76.4%, and AUC of 0.88. Notably, the overall diagnostic accuracy of nanopore sequencing was significantly higher than that of Mycobacterium tuberculosis (MTB) culture technique. Conclusion: Nanopore sequencing exhibited satisfactory overall diagnostic accuracy for smear-negative PTB, regardless of MTB culture status. Therefore, if conditions permit, nanopore sequencing is recommended as a diagnostic method for smear-negative PTB. Keywords: nanopore sequencing, smear-negative specimens, pulmonary tuberculosis, diagnostic accuracy Tuberculosis (TB) is a highly contagious disease caused by Mycobacterium tuberculosis (MTB), which continues to pose threats in the field of global health, as indicated by recent statistical data. 1 In 2022, 10.6 million new TB diagnoses and 1.3 million TB deaths were recorded worldwide. 1 Consequently, TB ranked among the top 10 causes of death attributed to a single infectious disease. 2 The most prevalent form of TB is pulmonary TB (PTB), accounting for approximately 70–85% of all TB cases. 3 PTB serves as the primary source of TB transmission. 4 Therefore, controlling the source of infection is crucial for reducing the spread of TB. Effective detection and treatment of PTB are key for controlling the source of infection effectively. Acid-fast bacilli (AFB) smear is the most widely used clinical method for diagnosing PTB. 5 However, it exhibits low sensitivity, indicating that a large proportion of patients present with a negative AFB smear. 6 Smear-negative PTB cases are easily overlooked, resulting in PTB transmission. 2 Improving the diagnostic accuracy of PTB using smear-negative clinical specimens remains a major challenge. Although MTB culture technique is essential for PTB diagnosis, it requires a long time and cannot facilitate early diagnosis. 7 Moreover, smear-negative PTB specimens may exhibit lower MTB content than smear-positive PTB specimens, resulting in a reduced culture positivity rate. 8 Consequently, relying solely on MTB culture technique for diagnosing smear-negative PTB may have limited efficacy. 9 The development of molecular diagnostic techniques in recent years has led to significant advancements in the rapid diagnosis of infectious diseases, including TB. 10,11 Xpert MTB/RIF is the most widely used molecular test for rapid diagnosis of TB recommended by the World Health Organization, also in China. 12 However, its accuracy in paucibacillary TB diagnosis still needs to be further improved. 13 Genetic sequencing is widely used in the field of infectious diseases and offers unique advantages for the rapid diagnosis of TB. 13,14 The utilization of next-generation sequencing (NGS) in TB has demonstrated remarkable diagnostic efficacy, thereby greatly improving TB diagnosis. 15 Nanopore sequencing is a unique and scalable technology that monitors changes in the current of nucleic acids as they pass through nanopore proteins. The resulting signal is decoded to provide specific DNA or RNA sequences. 16 Nanopore sequencing offers portability, real-time analysis, and long read lengths compared with other NGS techniques. 17,18 Its ability to directly detect and decode genetic material with high accuracy and efficiency will undoubtedly revolutionize various fields of research and significantly contribute to advancements in personalized medicine and molecular biology. I -Abstract Truncated-

A Comparison Study of CBNAAT, Gene Xpert and Line Probe Assays in the Diagnosis of Tuberculosis in smear Negative Specimens

Comparison of GeneXpert and line probe assay for detection of Mycobacterium tuberculosis and rifampicin-mono resistance at the National Tuberculosis Reference Laboratory, Kenya

Evaluation of GeneNAT Real-Time Polymerase Chain Reaction Analyzer and Pre-loaded Chip-Based Mycobacterium tuberculosis and Multidrug-Resistant Tuberculosis Detection in the Diagnosis of Pulmonary Tuberculosis

Performance Comparison of GeneXpert MTB/RIF, Gene Chip Technology, and Modified Roche Culture Method in Detecting Mycobacterium tuberculosis and Drug Susceptibility in Sputum

To Study the Role of Cartridge-Based Nucleic Acid Amplification Test (CBNAAT) in Early Diagnosis of Extra Pulmonary Tuberculosis

Multicenter Evaluation of the Biochip Assay for Rapid Detection of Mycobacterial Isolates in Smear-Positive Specimens

CBNAAT: An Emerging Xpert in Diagnosis of Head and Neck Tuberculosis

Evaluation of Nanopore Sequencing for Diagnosing Pulmonary Tuberculosis Using Negative Smear Clinical Specimens

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study

Synergy of Xpert (MTB/RIF) and Line probe assay for detection of rifampicin resistant strains of Mycobacterium tuberculosis

Comparison of the Diagnostic Efficacy of the CapitalBio Mycobacterium Real-Time Polymerase Chain Reaction Detection Test and Xpert MTB/RIF in Smear-Negative Pulmonary Tuberculosis

A preliminary evaluation of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis in bronchoalveolar lavage fluid specimens

Novel automated AIMLAM for diagnosis of Mycobacterium tuberculosis

Comparison of two molecular methods and an automated liquid culture system for the early detection of Mycobacterium tuberculosis from both pulmonary and extrapulmonary specimens in Kuwait

Accuracy of Nanopore Sequencing as a Diagnostic Assay for Pulmonary Tuberculosis versus Smear, Culture and Xpert MTB/RIF: A Head-to-Head Comparison

Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis

Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis

Diagnostic Accuracy of Nanopore Sequencing Using Respiratory Specimens in the Diagnosis of Pulmonary Tuberculosis.

Comparison of an in-house multiplex PCR with two commercial immuno-chromatographic tests for rapid identification and differentiation of MTB from NTM isolates

GeneXpert assay - A cutting-edge tool for rapid tissue diagnosis of tuberculous lymphadenitis

Nucleic acid amplification techniques for rapid diagnosis of nontuberculous mycobacteria: A protocol of systematic review and meta-analysis